NYSE ARCA | ETF
In seeking to track the performance of the index, the fund employs a replication strategy.
It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index.
The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 11.03% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 10.47% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.16% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.65% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.71% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.93% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.68% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.62% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.88% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.84% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.71% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.57% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.56% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.32% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.21% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 2.16% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.12% |
| ELV | Elevance Health Inc | Healthcare | Healthcare Plans | 1.79% |
| CI | Cigna Corp | Healthcare | Healthcare Plans | 1.73% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.55% |